GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
221 hedge funds and large institutions have $2.44B invested in Genomic Health, Inc. in 2019 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 48 increasing their positions, 84 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
43% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 84
52% less call options, than puts
Call options by funds: $1.5M | Put options by funds: $3.13M
Holders
221
Holding in Top 10
3
Calls
$1.5M
Puts
$3.13M
Top Buyers
| 1 | +$103M | |
| 2 | +$53.5M | |
| 3 | +$38.4M | |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$32.8M |
| 5 |
IA
IndexIQ Advisors
New York
|
+$29.9M |
Top Sellers
| 1 | -$44.6M | |
| 2 | -$43.5M | |
| 3 | -$41M | |
| 4 |
Goldman Sachs
New York
|
-$28.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$27M |